Arrowhead Pharmaceuticals Inc (ARWR)
Cash ratio
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 88,706 | 102,685 | 110,891 | 108,005 | 184,434 |
| Short-term investments | US$ in thousands | 692,818 | 578,276 | 292,735 | 268,391 | 183,355 |
| Total current liabilities | US$ in thousands | 195,487 | 103,168 | 105,456 | 138,850 | 146,536 |
| Cash ratio | 4.00 | 6.60 | 3.83 | 2.71 | 2.51 |
September 30, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($88,706K
+ $692,818K)
÷ $195,487K
= 4.00